Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program

Go back to Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program
(NASDAQ: DTIL) Delayed: 6.71 +0.15 (2.29%)
Previous Close $6.56    52 Week High $ 
Open $6.62    52 Week Low $ 
Day High $6.86    P/E N/A 
Day Low $6.55    EPS $ 
Volume 231,041